Compare CDXS & ANTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CDXS | ANTA |
|---|---|---|
| Founded | 2002 | 2022 |
| Country | United States | Singapore |
| Employees | N/A | 113 |
| Industry | Major Chemicals | Investment Bankers/Brokers/Service |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 256.3M | 209.7M |
| IPO Year | 2008 | N/A |
| Metric | CDXS | ANTA |
|---|---|---|
| Price | $2.47 | $8.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.17 |
| AVG Volume (30 Days) | ★ 1.1M | 1.7K |
| Earning Date | 05-07-2026 | 06-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.82 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $138,590,000.00 | N/A |
| Revenue This Year | $7.73 | $21.95 |
| Revenue Next Year | $14.24 | $30.46 |
| P/E Ratio | ★ N/A | $19.77 |
| Revenue Growth | ★ 32.30 | N/A |
| 52 Week Low | $0.96 | $6.25 |
| 52 Week High | $3.87 | $15.65 |
| Indicator | CDXS | ANTA |
|---|---|---|
| Relative Strength Index (RSI) | 50.12 | 44.17 |
| Support Level | $2.40 | $6.53 |
| Resistance Level | $2.67 | $9.81 |
| Average True Range (ATR) | 0.21 | 0.52 |
| MACD | -0.05 | -0.12 |
| Stochastic Oscillator | 21.43 | 11.28 |
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
Antalpha Platform Holding Co provides financing, technology and risk management solutions to institutional and corporate customers in the crypto asset industry. The company operates through Antalpha Prime platform in the following areas: Supply chain financing and Technology and services. Its revenue prominently consists of technology financing fees charged on the supply chain loans.